Like Dropprint Genomics

closed 3/25/2021 via BNC Analysis

Immunai, acquired Dropprint Genomics

synopsis: Immunai, a biotech company using single-cell biology and AI to power new therapeutic discoveries, has acquired Dropprint Genomics, a single-cell genomics software company. Dropprint develops software for doing data driven drug discovery in immunological diseases using single cell genomics and machine learning.
buyer: Immunai
Immunai is a biotech company using single-cell biology and AI to power new therapeutic discoveries. Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel discoveries. "
target: Dropprint Genomics
Dropprint Genomics is a single-cell genomics software company. Dropprint develops software for doing data driven drug discovery in immunological diseases using single cell genomics and machine learning. Their technology identifies gene data sets to help users better understand the immune system.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/25/2019 via PR Newswire

GraphPad Software, Inc., will acquire Geneious

synopsis: GraphPad, a leading provider of data analysis and visualization software for the life sciences industry, announced today that it will acquire Biomatters, a leading provider of Geneious DNA data analysis solutions.
buyer: GraphPad Software, Inc.
GraphPad is the leading provider of software developed exclusively for the scientific community. GraphPad Prism, their flagship product, is the preferred analysis and graphing solution for scientific research. Prism helps scientists discover and share the story in their data. "
target: Geneious
Biomatters, dba Geneious, empowers its customers with software that transforms biological data into insights across the spectrum of biotechnology research and development, including drug discovery, protein engineering and advanced comparative analysis of DNA, RNA and protein sequences.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2014 via PR Newswire

Roche Ltd, acquired Bina Technologies

synopsis: Bina Technologies, Inc. announced that they have been acquired by Roche. Bina Technologies is a privately held company that provides a big data platform for centralized management and processing of next generation sequencing (NGS) data for the academic and translational research markets. Bina will be integrated into the Roche Sequencing Unit.
buyer: Roche Ltd
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. "
target: Bina Technologies
Bina Technologies builds technologies for scalable and accurate processing and management of genomic information. Bina's Genomic Management Solution is an integrated and scalable analysis platform that empowers clinical and translational researchers to gain insight from their genomic data sets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/5/2016 via BNC Analysis

bioMérieux S.A., acquired Applied Maths

synopsis: bioMérieux, a world leader in the field of in vitro diagnostics, announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data.
buyer: bioMérieux S.A. (ENXTPA:BIM:$1,996.55)
A world leader in the field of in vitro diagnostics for 50 years, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. "
target: Applied Maths
Applied Maths develops cutting-edge software for the biosciences. The company has gained worldwide recognition with its software GelCompar for the analysis of 1D gel patterns, and later even more with BioNumerics, a software suite for integrated databasing and analysis of biological data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2021 via BusinessWire

W2O Group, acquired Swoop and IPM.ai

synopsis: W2O, a digital-first healthcare marketing agency, has acquired Swoop and IPM.ai, pioneers in using AI to solve big challenges in healthcare. Swoop provides precision healthcare marketing services for pharmaceutical companies. IPM.ai is an Insights as a Service provider that empowers life sciences companies to better understand their patients.
buyer parent: New Mountain Capital, LLC
buyer: W2O Group
W2O is an alchemic mix of 1,500 people and hundreds of clients and partners – working from bench to bedside – to make the world a healthier place. Driven by data, W2O applies proprietary analytics and best-in-class technology to build insights that power creative ideas and concepts. "
target: Swoop and IPM.ai
Swoop and IPM.ai are pioneers in using AI to solve big challenges in healthcare. Swoop provides precision healthcare marketing services for pharmaceutical companies. IPM.ai is an Insights as a Service provider that empowers life sciences companies to better understand their patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/13/2019 via BNC Analysis

IQVIA, acquired Linguamatics Limited

synopsis: Health analytics and contract research heavyweight IQvia has acquired bioinformatics company Linguamatics. Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text.
buyer: IQVIA (NYSE:IQV:$10,412.00)
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. "
target: Linguamatics Limited
Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text. They empower their customers to speed up drug development and improve patient outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/23/2017 via PR Newswire

Chan Zuckerberg Initiative, will acquire Meta Inc.

synopsis: iGan Partners announced the pending acquisition of its portfolio company, Meta, by the Chan Zuckerberg Initiative. Meta uses artificial intelligence to read the world's scientific papers, understand what is in them, and deliver their insights to researchers in real time.
buyer: Chan Zuckerberg Initiative
The Chan Zuckerberg Initiative was launched by Facebook founder and CEO Mark Zuckerberg and Dr. Priscilla Chan, pediatrician and founder of the Primary School. CZI seeks to advance human potential and promote equality. "
target parent: iGan Partners
target: Meta Inc.
Toronto-based tech company Meta helps researchers understand what is happening globally in science, and shows them where science is headed. Meta uses artificial intelligence to read the world's scientific papers, understand what is in them, and deliver their insights to researchers in real time.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2020 via Company Press Release

Phlexglobal, acquired Cunesoft

synopsis: Phlexglobal, the leading provider of Trial Master File (TMF) software and expert services, has acquired Cunesoft, a European leader in cloud-based regulatory software solutions for the life sciences industry. Cunesoft offers a machine learning powered regulatory compliance software suite for compliant document, data and submission management.
buyer parent: Vitruvian Partners LLP
buyer: Phlexglobal
Phlexglobal is the world-leading specialist provider of electronic Trial Master File (eTMF) systems and services to the life sciences industry. Phlexglobal leverages authoritative TMF technologies and expert services to bring order, stability, and control to their client's Trial Master File. "
target: Cunesoft
Cunesoft is a European leader in cloud-based regulatory software solutions and services for all segments within the life sciences industry. Cunesoft offers a machine learning powered regulatory compliance software suite for compliant document, data and submission management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/6/2016 via Company Press Release

Sunquest Information Systems, acquired GeneInsight

synopsis: Sunquest Information Systems Inc., a company that provides laboratory information systems, announced the acquisition of GeneInsight Inc., an IT company that streamlines the analysis, interpretation and reporting of complex genetic tests.
buyer parent: Roper Technologies, Inc.
buyer: Sunquest Information Systems
Sunquest Information Systems Inc. provides laboratory information systems to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories across the world optimize financial results, enhance efficiency and improve the quality of patient care. "
target: GeneInsight
GeneInsight Inc. is an IT company that streamlines the analysis, interpretation and reporting of complex genetic tests. GeneInsight Suite® was developed in collaboration with leading geneticists, laboratory operations personnel, practicing physicians and IT professionals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/1/2021 via BusinessWire

Instem, acquired The Edge Software Consultancy Ltd.

synopsis: Instem, a leading provider of IT solutions and services to the global life sciences market, has acquired The Edge Software Consultancy Ltd., a UK-based software company specializing in the pharmaceutical and biotechnology industry. The Edge focuses on improving the efficiency of drug discovery research and development.
buyer: Instem (AIM:INS:$38.71)
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide. "
target: The Edge Software Consultancy Ltd.
The Edge is a UK-based software company specializing in the pharmaceutical and biotechnology industry. The Edge focuses on improving the efficiency of drug discovery research and development. Their BioRails platform enables automated data capture over the entire research and development process.
price ($mm)
$7.88
rev ($mm)
$3
EBITDA ($mm)
EV / rev
3.1x
EV / EBITDA
closed 6/12/2014 via Company Press Release

Wiley, acquired SimBioSys Inc.

synopsis: John Wiley & Sons, Inc., a global provider of knowledge and knowledge-enabled solutions that improve outcomes in research, professional practice, and education, announced that it has acquired SimBioSys Inc., a provider of scientific software tools that facilitate the drug discovery process.
buyer: Wiley (NYSE:JW.A:$1,864.09)
Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice, and education. "
target: SimBioSys Inc.
SimBioSys is a recognized leader in the field of rational drug discovery software. Providing a wide range of software solutions, the company is focused on the development of scientific tools to facilitate the drug discovery process.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/17/2012 via PR Newswire

Accelrys Software Inc., purchased Hit Explorer Operating System (HEOS) from SCYNEXIS, Inc.

synopsis: Accelrys, Inc. announced that it has purchased the Web-based Hit Explorer Operating System (HEOS) from SCYNEXIS, Inc. HEOS enables more efficient and streamlined drug discovery collaborations, particularly for organizations leveraging academic departments, research institutes and contract research organizations in externalized R&D projects.
buyer: Accelrys Software Inc. (ACCL:$166.25)
Accelrys, Inc. is a leading scientific enterprise R&D software and services company that supports industries and organizations that rely on scientific innovation to differentiate themselves. Headquartered in San Diego, Calif., Accelrys employs more than 200 full-time PhD scientists. "
seller: SCYNEXIS, Inc.
HEOS® is a comprehensive web-based drug research information management software platform that supports geographically-distributed scientists and facilitates collaboration. It is heavily used by users around the world including large pharmaceutical companies and biotechnology companies.
price ($mm)
$4.50
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/18/2007 via BusinessWire

First Consulting Group, acquired Zorch, Inc.

synopsis: First Consulting Group, Inc., announced the acquisition of Zorch, Inc., a Salt Lake City, Utah based company that has built a proprietary enterprise software solution to provide regulated content management and collaboration for the life sciences industry.
buyer: First Consulting Group (FCGI:$0.00)
First Consulting Group is a leading provider of outsourcing, consulting, systems implementation and integration services and proprietary software products for healthcare, pharmaceutical, and other life sciences organizations throughout North America, Europe and Asia. "
target: Zorch, Inc.
Zorch Software offers software, services and consulting to biotech, pharmaceutical, and medical device companies. With combined expertise in technology, enterprise management, and FDA regulated processes, Zorch expedites the product and drug development process to save companies time and money.
price ($mm)
$2.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,323.17)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/11/2018 via Company Press Release

Genpact Ltd, will acquire Commonwealth Informatics Inc.

synopsis: Genpact, a professional services firm focused on delivering digital transformation, announced that it has signed a definitive agreement to acquire Commonwealth Informatics, Inc. (CI), a market-leading provider of cloud-based drug safety analytics products and services for medical research and healthcare delivery headquartered near Boston, Mass.
buyer: Genpact Ltd (G:$3,699.55)
Genpact is a global professional services firm that makes business transformation real. They drive digital-led innovation and digitally-enabled intelligent operations for their clients. They think with design, dream in digital, and solve problems with data and analytics. "
target: Commonwealth Informatics Inc.
Commonwealth Informatics provides cloud-based drug safety analytics products and services for medical research and healthcare delivery. Their Commonwealth Vigilance Workbench consists of integrated modules used by pharmaceutical and biotech companies, government agencies, and healthcare providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2014 via PR Newswire

Decision Resources Group, acquired Relay Technology Management

synopsis: Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Relay Technology Management
Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/13/2019 via BusinessWire

Saama Technologies, will acquire Comprehend Systems, Inc.

synopsis: Saama Technologies, Inc., the advanced clinical data and analytics company, announced that it has signed a definitive agreement to acquire Comprehend Systems, Inc., a company that provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process.
buyer: Saama Technologies
Saama Technologies is the advanced clinical data and analytics company, unleashing wisdom from data to deliver better actionable business outcomes for the life sciences industry. "
target: Comprehend Systems, Inc.
Comprehend provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process. Their solutions deliver actionable risk and performance insights across studies, systems, sites, and vendors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/15/2016 via PR Newswire

The WIRB-Copernicus Group, will purchase Clinical Trial Applications from karmadata

synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality of clinical research, will acquire from karmadata a suite of proprietary applications designed to facilitate the management of clinical trial data. karmadata is the market leader in clinical trial database and decision support applications.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
seller: karmadata
Karmadata is able to standardize and link the world's healthcare data ranging from leading open data sources to priva pharmacy and medical claims. Its propriety applications are designed to facilitate the management of clinical trial data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/6/2015 via BusinessWire

IMS Health Incorporated, acquired Dataline Software

synopsis: IMS Health has acquired Dataline Software, a leader in Big Data analytics for healthcare. U.K.-based Dataline has worked closely with life sciences companies, payers, healthcare authorities and academia to deliver tailored software for rapid analysis and elegant visualizations of large, complex healthcare data sets.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
target: Dataline Software
Dataline is a software solutions company specializing in big-data analytics solutions for healthcare. They also provide consultancy, training, system implementation, application development and technical support to a wide and varied client base.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2021 via BNC Analysis

Immunai, acquired Dropprint Genomics

synopsis: Immunai, a biotech company using single-cell biology and AI to power new therapeutic discoveries, has acquired Dropprint Genomics, a single-cell genomics software company. Dropprint develops software for doing data driven drug discovery in immunological diseases using single cell genomics and machine learning.
buyer: Immunai
Immunai is a biotech company using single-cell biology and AI to power new therapeutic discoveries. Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel discoveries. "
target: Dropprint Genomics
Dropprint Genomics is a single-cell genomics software company. Dropprint develops software for doing data driven drug discovery in immunological diseases using single cell genomics and machine learning. Their technology identifies gene data sets to help users better understand the immune system.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2021 via BNC Analysis

Immunai, acquired Dropprint Genomics

synopsis: Immunai, a biotech company using single-cell biology and AI to power new therapeutic discoveries, has acquired Dropprint Genomics, a single-cell genomics software company. Dropprint develops software for doing data driven drug discovery in immunological diseases using single cell genomics and machine learning.
buyer: Immunai
Immunai is a biotech company using single-cell biology and AI to power new therapeutic discoveries. Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel discoveries. "
target: Dropprint Genomics
Dropprint Genomics is a single-cell genomics software company. Dropprint develops software for doing data driven drug discovery in immunological diseases using single cell genomics and machine learning. Their technology identifies gene data sets to help users better understand the immune system.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2021 via BNC Analysis

Immunai, acquired Dropprint Genomics

synopsis: Immunai, a biotech company using single-cell biology and AI to power new therapeutic discoveries, has acquired Dropprint Genomics, a single-cell genomics software company. Dropprint develops software for doing data driven drug discovery in immunological diseases using single cell genomics and machine learning.
buyer: Immunai
Immunai is a biotech company using single-cell biology and AI to power new therapeutic discoveries. Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel discoveries. "
target: Dropprint Genomics
Dropprint Genomics is a single-cell genomics software company. Dropprint develops software for doing data driven drug discovery in immunological diseases using single cell genomics and machine learning. Their technology identifies gene data sets to help users better understand the immune system.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2021 via BusinessWire

W2O Group, acquired Swoop and IPM.ai

synopsis: W2O, a digital-first healthcare marketing agency, has acquired Swoop and IPM.ai, pioneers in using AI to solve big challenges in healthcare. Swoop provides precision healthcare marketing services for pharmaceutical companies. IPM.ai is an Insights as a Service provider that empowers life sciences companies to better understand their patients.
buyer parent: New Mountain Capital, LLC
buyer: W2O Group
W2O is an alchemic mix of 1,500 people and hundreds of clients and partners – working from bench to bedside – to make the world a healthier place. Driven by data, W2O applies proprietary analytics and best-in-class technology to build insights that power creative ideas and concepts. "
target: Swoop and IPM.ai
Swoop and IPM.ai are pioneers in using AI to solve big challenges in healthcare. Swoop provides precision healthcare marketing services for pharmaceutical companies. IPM.ai is an Insights as a Service provider that empowers life sciences companies to better understand their patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/13/2019 via BNC Analysis

IQVIA, acquired Linguamatics Limited

synopsis: Health analytics and contract research heavyweight IQvia has acquired bioinformatics company Linguamatics. Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text.
buyer: IQVIA (NYSE:IQV:$10,412.00)
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. "
target: Linguamatics Limited
Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text. They empower their customers to speed up drug development and improve patient outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/23/2017 via PR Newswire

Chan Zuckerberg Initiative, will acquire Meta Inc.

synopsis: iGan Partners announced the pending acquisition of its portfolio company, Meta, by the Chan Zuckerberg Initiative. Meta uses artificial intelligence to read the world's scientific papers, understand what is in them, and deliver their insights to researchers in real time.
buyer: Chan Zuckerberg Initiative
The Chan Zuckerberg Initiative was launched by Facebook founder and CEO Mark Zuckerberg and Dr. Priscilla Chan, pediatrician and founder of the Primary School. CZI seeks to advance human potential and promote equality. "
target parent: iGan Partners
target: Meta Inc.
Toronto-based tech company Meta helps researchers understand what is happening globally in science, and shows them where science is headed. Meta uses artificial intelligence to read the world's scientific papers, understand what is in them, and deliver their insights to researchers in real time.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2020 via Company Press Release

Phlexglobal, acquired Cunesoft

synopsis: Phlexglobal, the leading provider of Trial Master File (TMF) software and expert services, has acquired Cunesoft, a European leader in cloud-based regulatory software solutions for the life sciences industry. Cunesoft offers a machine learning powered regulatory compliance software suite for compliant document, data and submission management.
buyer parent: Vitruvian Partners LLP
buyer: Phlexglobal
Phlexglobal is the world-leading specialist provider of electronic Trial Master File (eTMF) systems and services to the life sciences industry. Phlexglobal leverages authoritative TMF technologies and expert services to bring order, stability, and control to their client's Trial Master File. "
target: Cunesoft
Cunesoft is a European leader in cloud-based regulatory software solutions and services for all segments within the life sciences industry. Cunesoft offers a machine learning powered regulatory compliance software suite for compliant document, data and submission management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,323.17)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 1/6/2006 via BusinessWire

Wolters Kluwer NV, purchased pharmaceutical information management business from NDCHealth

synopsis: Wolters Kluwer, based in Amsterdam, the Netherlands, purchased the pharmaceutical information management business from NDCHealth.
buyer parent: Wolters Kluwer NV
buyer: Wolters Kluwer NV
Wolters Kluwer Health is a leading provider of information for professionals and students in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks. "
seller: NDCHealth
NDCHealth has been providing integrated information support to all segments of the health industry for over two decades. This experience, leveraged with our powerful network capabilities, has built our reputation as an innovative provider of end-to-end business solutions.
price ($mm)
$382
rev ($mm)
$165
EBITDA ($mm)
$36
EV / rev
2.3x
EV / EBITDA
10.6x
closed 10/9/2019 via BNC Analysis

Mevex Corporation, acquired Konnexis Inc.

synopsis: Mevex Corporation announced the acquisition of Konnexis Inc., a global market innovator in medical device sterilization control systems and software development. Konnexis is dedicated to providing future-proof control and monitoring systems for sterilizers. Its control systems are being used throughout the world.
buyer: Mevex Corporation
Mevex is a highly respected services and products provider for the international medical device sterilization and radiation processing industries. The company designs and builds high power linear accelerator systems for Electron Beam and X-Ray processing. "
target: Konnexis Inc.
Konnexis is a global market innovator in medical device sterilization control systems and software development. Konnexis is dedicated to providing future-proof control and monitoring systems for sterilizers. Its control systems are being used throughout the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$8,793.96)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 12/23/2015 via BusinessWire

QPharma, Inc., acquired Qforma, Inc.

synopsis: QPharma, a premier provider of compliance and commercial services to the life sciences industry, announced the acquisition of Qforma, Inc. Qforma offers an array of life sciences solutions that include healthcare analytics, predicitive modeling, and product launch services.
buyer: QPharma, Inc.
QPharma provides a suite of solutions to the life sciences industry. Services offered by the company’s Professional Services division include validation services, project management, auditing, and training. "
target parent: BelHealth Investment Partners
target: Qforma, Inc.
Qforma is a leading provider of social analytics for the life sciences industry. Based on advanced data and analytics, Qforma helps its clients to understand, monitor and predict behavior in all relevant communities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2014 via PR Web

Cision AB, Vocus, Inc., acquired Visible Technologies

synopsis: Vocus, Inc. and Cision, leading global providers of cloud-based public relations software have been brought together by private equity firm GTCR, announced the acquisition of Visible Technologies. Visible is a worldwide market leader in social media listening and analytics, insights and engagement.
buyer: Cision AB (:$739.91)
buyer: Vocus, Inc.
Vocus is a leading provider of public relations software that enables professionals to plan, execute and measure influencer-oriented campaigns in one integrated platform. Cision is a leading provider of cloud-based PR software, services and tools for the marketing and public relations industry. "
target: Visible Technologies
Visible Technologies is the leader in social media monitoring, analytics, and services for enterprises globally. Visible helps businesses analyze social media conversations to better understand consumer preferences, market dynamics, competitive strengths and weaknesses, and other information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/6/2013 via PR Newswire

Qforma, Inc. merged with SkilaMederi,

synopsis: SkilaMederi, a global life-sciences social analytics strategic solutions and launch optimization provider, and Qforma, a leading provider of advanced analytics and predictive technologies for the life sciences industry, announce their merger.
buyer parent: BelHealth Investment Partners
buyer: SkilaMederi
SkilaMederi is a leading provider of global product launch optimization and stakeholder engagement insight that drive measurable value for life sciences companies. SkilaMederi serves medical, marketing, market access and sales teams at pharmaceutical, biotechnology and medical device companies. "
target: Qforma, Inc.
Qforma empowers its healthcare customers with actionable insights, quantified metrics, and timely alerts to impending change. Qforma is a leader in Community Opinion Leader mapping, which is critical as healthcare companies continue to educate physicians about new therapies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/20/2006 via

PharmaTech Solutions Inc., acquired Realinterface Expert Systems, Inc.

synopsis: PharmaTech Solutions, Inc. announced that it has signed a Letter Of Intent to acquire Realinterface Expert Systems, Inc. Technology based RESI developed and recently introduced the InClinix software system, and has demonstrated initial success in the pharmaceutical clinical development markets.
buyer: PharmaTech Solutions Inc.
PharmaTech Solutions (PTS) is an integrated clinical development services company founded in 1999. PTS clients include major pharmaceutical, biotechnology and medical device organizations across the U.S. "
target: Realinterface Expert Systems, Inc.
Realinterface Expert Systems develops and markets InClinix, a clinical trial recruiting and management software application. InClinix accelerates enrollment and improves the quality of data collected during candidate interviews.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/21/2020 via PR Newswire

Elsevier B.V., acquired SciBite

synopsis: Elsevier, a global research publishing and information analytics provider, and part of RELX, has acquired SciBite, a semantic AI company headquartered in Cambridge, UK, to help customers make faster, more effective R&D decisions through advanced text and data intelligence solutions.
buyer parent: RELX Group plc
buyer: Elsevier B.V.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers and tackle human crises. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education. "
target: SciBite
SciBite offer a complete semantic services platform for life sciences that can be used as a data analytics solution by end users and also as a 'pluggable' component to transform existing IT infrastructures into more scientifically aware systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/21/2018 via Company Press Release

Melissa, acquired IO Informatics, Inc.

synopsis: Melissa, a leading provider of global contact data quality and identity verification solutions, launched Melissa Informatics, fueled by its acquisition of semantic technology firm, IO Informatics (IOI). IOI’s software and services support global leaders in life sciences, reducing time and cost to benefit from clean, richly connected data.
buyer: Melissa
Melissa provides identity verification and contact data quality for over 10,000 customers worldwide, helping profile, cleanse, update, match and enrich People Data to prevent fraud, decrease costs, drive revenue and improve customer communications. "
target: IO Informatics, Inc.
Semantic technology firm, IO Informatics (IOI), provides software and services to support global leaders in life sciences, biotechnology, pharmaceutical, and medical industries, reducing time and cost to benefit from clean, richly connected data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/28/2015 via BusinessWire

Expert System S.p.A., will acquire TEMIS S.A.

synopsis: Expert System, the leader in semantic technology for the effective management of unstructured information, announced an agreement to acquire TEMIS, a leader in text analytics solutions. With the acquisition of TEMIS, Expert System will become the leading global provider of semantic technology for cognitive computing.
buyer: Expert System S.p.A. (:$13.44)
Expert System is a provider of information access solutions based on the proprietary, patented technology of Cogito. Expert System's products provide enterprise companies the ability to go beyond traditional keyword approaches for the rapid sense-making of their structured and unstructured data. "
target: TEMIS S.A.
TEMIS helps organizations structure, manage and leverage their unstructured information assets. Its flagship platform, Luxid®, identifies and extracts targeted information to semantically enrich content with domain-specific metadata.
price ($mm)
$13
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/13/2017 via PR Newswire

SciBite, acquired FactBio Ltd

synopsis: SciBite, a firm whose technology is revolutionising R&D for pharmaceutical companies across the globe, has acquired Cambridge based FactBio, a leading developer of semantic software for data management and curation for the life sciences.
buyer: SciBite
SciBite offer a complete semantic services platform for life sciences that can be used as a data analytics solution by end users and also as a 'pluggable' component to transform existing IT infrastructures into more scientifically aware systems. "
target: FactBio Ltd
FactBio is a leading developer of semantic software for data management and curation for the life sciences. FactBio builds ontologies and tools for the curation and management of scientific data. The company's focus is on biomedical data, with the potential to apply its tools more widely.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2015 via BNC Analysis

Aurea, acquired NextDocs Corporation

synopsis: NextDocs, a global leader in providing Microsoft SharePoint-based compliance solutions to life sciences organizations, was acquired by Aurea Software. NextDocs provides solutions for managing regulatory documents, SOPs, and clinical documents, as well as a full set of quality processes from CAPA to complaints.
buyer parent: ESW Capital, LLC
buyer: Aurea
Aurea enables companies to deliver transformative customer experiences. Their Customer Experience Platform helps customers build, execute, monitor and optimize the customer journey for a diverse range of industries including energy, retail, insurance, travel and hospitality, and life sciences. "
target: NextDocs Corporation
NextDocs is the global leader in compliance innovation for life sciences organizations. NextDocs provides solutions for managing regulatory documents, SOPs, and clinical documents, as well as a full set of quality processes from CAPA to complaints.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/7/2021 via BusinessWire

Change Healthcare Corporation will be merged with Optum,

synopsis: Optum, a diversified health services company, and Change Healthcare, a health care technology leader, are to merge. Change Healthcare will join with OptumInsight to provide software and data analytics, technology-enabled services and research, advisory and revenue cycle management offerings to help make health care work better for everyone.
buyer parent: UnitedHealth Group
buyer: Optum
Optum is a health services and innovation company on a mission to help make the health system work better for everyone. They combine data and analytics with technology and expertise to power modern health care. "
target: Change Healthcare Corporation (CHNG:$1,646.91)
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
price ($mm)[EV]
$8,616 [$13,440]
rev ($mm)
$2,432
EBITDA ($mm)
EV / rev
5.6x
EV / EBITDA
closed 12/9/2020 via Company Press Release

ZEISS Group, acquired Arivis

synopsis: ZEISS, an international technology enterprise operating in the fields of optics and optoelectronics, has acquired a majority stake in arivis, a biomedical software company in Germany. arivis enables users to visualize and manage multi-dimensional image datasets. Their platform features solutions for imaging, compliance, data management, and more.
buyer: ZEISS Group (XTRA:AFX:$1,364.13)
ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. The ZEISS Group develops, produces and distributes measuring technology, microscopes, medical technology, eyeglass lenses, camera and cinema lenses, binoculars and more. "
target: Arivis
arivis is a biomedical big image data and compliance software company in Germany. arivis enables users to visualize, analyze, distribute and manage multi-terabyte, multi-dimensional image datasets. Their cloud-based platform features solutions for imaging, compliance, data management, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Dropprint Genomics


read more

Dropprint Genomics

Geneious

Bina Technologies

Applied Maths

Swoop and IPM.ai

Linguamatics Limited

Meta Inc.

Cunesoft

GeneInsight

The Edge Software Consultancy Ltd.

SimBioSys Inc.

SCYNEXIS, Inc.

Zorch, Inc.

Medidata

Medimix International

Commonwealth Informatics Inc.

Relay Technology Management

Comprehend Systems, Inc.

karmadata

Dataline Software

read more

Dropprint Genomics

read more

Dropprint Genomics

read more

Dropprint Genomics

Swoop and IPM.ai

Linguamatics Limited

Meta Inc.

Cunesoft

Medidata

NDCHealth

Konnexis Inc.

Invicro, LLC

Qforma, Inc.

Visible Technologies

Qforma, Inc.

Realinterface Expert Systems, Inc.

SciBite

IO Informatics, Inc.

TEMIS S.A.

FactBio Ltd

NextDocs Corporation

Change Healthcare Corporation

Arivis

Geography
Matching Companies
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2020
rev ($mm)
$38.71
EBITDA ($mm)
$6.69
EBIT ($mm)
$5.66
Net Income ($mm)
$0.47
Employees
268
  • drill down
  • watch
Ticker: SLP
 
 
 
 
 
 
 
 
Simulations Plus, Inc.
Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software that is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide.
year
2019
rev ($mm)
$35.84
EBITDA ($mm)
$12.38
EBIT ($mm)
$11.28
Net Income ($mm)
$9.11
Employees
109
  • drill down
  • watch
Ticker: POAI
 
 
 
 
 
 
 
 
Predictive Oncology Inc.
Predictive Oncology Inc.
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery. Predictive Oncology operates through five segments which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe.
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($13.26)
EBIT ($mm)
($13.71)
Net Income ($mm)
Employees
24
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: CNSX:PHGI
 
 
 
 
 
 
 
 
Premier Health Group Inc.
Premier Health is strategically poised to take advantage of business opportunities in the global health care industry. Their subsidiary, HealthVue, is focused on developing proprietary technology to deliver quality healthcare through the combination of telemedicine and artificial intelligence (AI).
year
2020
rev ($mm)
$9.28
EBITDA ($mm)
($6.35)
EBIT ($mm)
($6.38)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: AIM:CRON
 
 
 
 
 
 
 
 
Cronin Group PLC
Cronin Group PLC provides medical research and development services. The Company focuses on the discovery, development, and manufacture of small molecules and nano-materials utilizing proprietary chemistry. Cronin Group offers its services in the United Kingdom.
year
2018
rev ($mm)
EBITDA ($mm)
($2.29)
EBIT ($mm)
($2.34)
Net Income ($mm)
Employees
25
  • drill down
  • watch
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2020
rev ($mm)
$906.40
EBITDA ($mm)
$100.91
EBIT ($mm)
$61.95
Net Income ($mm)
$49.09
Employees
2780
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: LEON
 
 
 
 
 
 
 
 
LION bioscience AG
At the heart of LION’s offering is SRS, the world’s leading integration software for biological data, which seamlessly integrates information from hundreds of publicly available databases with in-house research data.
year
2004
rev ($mm)
$32.30
EBITDA ($mm)
($57.50)
EBIT ($mm)
($76.30)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: TSXV:DNAX
 
 
 
 
 
 
 
 
BLOCKStrain
BLOCKStrain
BLOCKStrain Technology Corp. has developed the first integrated blockchain platform that registers and tracks intellectual property for the cannabis industry. They are based in Vancouver, BC, Canada.
year
2018
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: TSXV:CRBK
 
 
 
 
 
 
 
 
Carebook Technologies Inc.
Carebook Technologies Inc.
Built on a powerful health platform, Carebook creates highly engaging, customer-centric digital products for pharmacies, insurance providers, governments, businesses, and more. Carebook’s core is science and technology, and its goal is accessible, connected health for everyone.
year
2020
rev ($mm)
$2.87
EBITDA ($mm)
($4.24)
EBIT ($mm)
($4.44)
Net Income ($mm)
Employees
38
  • drill down
  • watch
Ticker: CHNG
 
 
 
 
 
 
 
 
Change Healthcare Corporation
Change Healthcare Corporation
Change Healthcare is a leading independent healthcare technology company that provides data and analytics-driven solutions to improve clinical, financial and patient engagement outcomes in the U.S. healthcare system.
year
2020
rev ($mm)
$1,646.91
EBITDA ($mm)
EBIT ($mm)
($155.95)
Net Income ($mm)
Employees
15000
  • drill down
  • watch
Ticker: POAI
 
 
 
 
 
 
 
 
Predictive Oncology Inc.
Predictive Oncology Inc.
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery. Predictive Oncology operates through five segments which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe.
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($13.26)
EBIT ($mm)
($13.71)
Net Income ($mm)
Employees
24
  • drill down
  • watch
Ticker: MRCY
 
 
 
 
 
 
 
 
Mercury Computer Systems, Inc.
Mercury Computer Systems, Inc.
Mercury Computer Systems is the leading supplier of high-performance digital signal and image processing systems. These embedded computer systems transform streams of sensor data to visual information in real time for analysis and interpretation.
year
2011
rev ($mm)
$228.71
EBITDA ($mm)
$33.90
EBIT ($mm)
$25.55
Net Income ($mm)
$18.44
Employees
602
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: CNSX:PHGI
 
 
 
 
 
 
 
 
Premier Health Group Inc.
Premier Health is strategically poised to take advantage of business opportunities in the global health care industry. Their subsidiary, HealthVue, is focused on developing proprietary technology to deliver quality healthcare through the combination of telemedicine and artificial intelligence (AI).
year
2020
rev ($mm)
$9.28
EBITDA ($mm)
($6.35)
EBIT ($mm)
($6.38)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: AIM:CRON
 
 
 
 
 
 
 
 
Cronin Group PLC
Cronin Group PLC provides medical research and development services. The Company focuses on the discovery, development, and manufacture of small molecules and nano-materials utilizing proprietary chemistry. Cronin Group offers its services in the United Kingdom.
year
2018
rev ($mm)
EBITDA ($mm)
($2.29)
EBIT ($mm)
($2.34)
Net Income ($mm)
Employees
25
  • drill down
  • watch
Ticker: TSE:4543
 
 
 
 
 
 
 
 
Terumo Corporation
Terumo Corporation
Terumo is a global leader in medical technology. The company's business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems and diabetes care.
year
2020
rev ($mm)
$5,694.98
EBITDA ($mm)
$1,437.51
EBIT ($mm)
$927.04
Net Income ($mm)
$721.22
Employees
26438
  • drill down
  • watch
Ticker: VAR
 
 
 
 
 
 
 
 
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Varain Medical Systems produces tools that harness the power of X-ray energy to benefit humankind. They have made developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing.
year
2018
rev ($mm)
$2,888.20
EBITDA ($mm)
$597.60
EBIT ($mm)
$525.70
Net Income ($mm)
$143.20
Employees
6600
  • drill down
  • watch
Ticker: DXCM
 
 
 
 
 
 
 
 
Dexcom, Inc.
Dexcom, Inc.
DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare providers.
year
2018
rev ($mm)
$832.50
EBITDA ($mm)
($2.90)
EBIT ($mm)
($24.10)
Net Income ($mm)
Employees
2290
  • drill down
  • watch
Ticker: OTCPK:IGMB.D
 
 
 
 
 
 
 
 
Clinigence, LLC.
Clinigence Holdings, a fully reporting, publicly-held company, is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: TSXV:EYC
 
 
 
 
 
 
 
 
Binovi
Binovi
Binovi is a neuro-vision enhancement platform that is designed for vision optimization and the enhancement of cognitive skills related to human performance. Binovi helps improve the lives of the 1 in 4 individuals who suffer from some form of visual impairment besides acuity loss.
year
2020
rev ($mm)
$0.42
EBITDA ($mm)
($4.63)
EBIT ($mm)
($4.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: OTCQB: EHVVF
 
 
 
 
 
 
 
 
Ehave, Inc.
Ehave, Inc.
Ehave is a healthcare company developing a next generation of digital solutions for stakeholders in the medical cannabis and mental health sectors. Ehave’s health informatics platform efficiently captures high-quality, objective user data.
year
2018
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.76)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: CERN
 
 
 
 
 
 
 
 
Cerner Corporation
Cerner Corporation
Cerner's health information technologies connect people, information, and systems. Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations.
year
2020
rev ($mm)
$5,552.99
EBITDA ($mm)
$1,247.29
EBIT ($mm)
$792.06
Net Income ($mm)
$792.91
Employees
27400
  • drill down
  • watch
Ticker: 300253
 
 
 
 
 
 
 
 
Shanghai Kingstar Winning Software Co., Ltd.
Shanghai Kingstar Winning Software is principally engaged in the development of medical software, the provision of technology services and the distribution of hardware products. They primarily offer software, including hospital information systems and public health information management systems.
year
2015
rev ($mm)
$98.42
EBITDA ($mm)
$14.01
EBIT ($mm)
$12.72
Net Income ($mm)
$21.57
Employees
454
  • drill down
  • watch